Arcutis Biotherapeutics, Inc. (ARQT)
20.66
-3.51
(-14.52%)
USD |
NASDAQ |
May 07, 16:00
20.80
+0.14
(+0.68%)
After-Hours: 17:20
Arcutis Biotherapeutics SG&A Expense (TTM) : 274.55M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Repligen Corp. | 219.25M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Corcept Therapeutics, Inc. | 503.42M |
| Amicus Therapeutics, Inc. | 383.49M |
| PTC Therapeutics, Inc. | 347.14M |